Loading clinical trials...
Loading clinical trials...
The most aggressive primary brain tumors in adults, glioblastomas, are characterized by a profound local and systemic immune suppression. During tumor progression, the infiltration of inflammatory leu...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Istituto Oncologico Veneto IRCCS
Collaborators
NCT05271240 · Glioblastoma, Glioblastoma Multiforme, and more
NCT05954858 · Glioma, Malignant, Glioblastoma, and more
NCT06636162 · Glioma, Malignant, IDH Mutation
NCT06468176 · Glioma, Malignant
NCT06942104 · Solid Tumor, Solid Carcinoma, and more
University Hospital
Florence
University Hospital
Padua
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions